Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NUDCD2 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | PSPC1 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | HNF1A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | INTS12 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | AGPAT4 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
mRNA | ZNF546 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | NEDD8-MDP1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | KDM3A | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | PEX7 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
mRNA | CNN3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |